Physician profile
Roger K Muse
NPI 1700885324
$2,513.72
in general payments reported to CMS, 2019-2025
20 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $512 · 2021: $343 · 2022: $421 · 2023: $292 · 2024: $206 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $694.95 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $443.98 | 2019-2025 | Watchman Flx, Watchman Access System, Ingevity+ |
| Novartis Pharmaceuticals Corporation | $426.59 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $306.87 | 2020-2023 | Xarelto |
| Pfizer INC. | $97.50 | 2020-2024 | |
| Abiomed | $79.09 | 2023 | Impella |
| Irhythm Technologies, INC. | $68.61 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Amarin Pharma, INC. | $63.99 | 2020 | |
| Cvrx, INC. | $45.60 | 2024-2025 | Barostim Neo System |
| Daiichi Sankyo INC. | $44.49 | 2023 | Injectafer |
| Merck Sharp & Dohme LLC | $37.36 | 2021 | |
| Amgen INC. | $35.00 | 2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $28.38 | 2020-2022 | |
| Atricure, INC. | $27.15 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Cardiva Medical, INC. | $24.60 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $22.67 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.13 | 2023 | Jardiance |
| Abbott Laboratories | $16.83 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.57 | 2024 | |
| Braemar Manufacturing, LLC | $16.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Muse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.